Haaretz Breaking News View in browser

Teva to cut 7,000 jobs after reports massive Q2 loss; stock plunges Pharma giant to shut 15 plants in 2017-2018; pull out of 45 countries after profit miss and slashed outlook. Sales of Teva's best-selling drug Copaxone fall drastically Yoram Gabison, Haaretz and Reuters | 03.08.2017 Read More

For more Haaretz newsletters, click here. Unsubscribe from mailing list. Contact Customer support. All rights reserved © Haaretz Daily Newspaper Ltd. Shvil Hameretz 2, Tel Aviv, 61350, Israel. Company Registration No. 51-001544-9 | Database No: 1091365.